Portal de Periódicos da CAPES

Prevalence of symptoms experienced by patients with different clinical types of psoriasis

2004; Oxford University Press; Volume: 151; Issue: 3 Linguagem: Inglês

10.1111/j.1365-2133.2004.06093.x

1365-2133

Francesca Sampogna, Paolo Gisondi, C.F. Melchi, Paolo Amerio, Giampiero Girolomoni, Damiano Abeni,

Nail Diseases and Treatments

British Journal of DermatologyVolume 151, Issue 3 p. 594-599 Prevalence of symptoms experienced by patients with different clinical types of psoriasis F. Sampogna, F. Sampogna Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorP. Gisondi, P. Gisondi Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorC.F. Melchi, C.F. Melchi Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorP. Amerio, P. Amerio Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorG. Girolomoni, G. Girolomoni Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorD. Abeni, D. Abeni Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorThe Idi Multipurpose Psoriasis Research on Vital Experiences (Improve) Investigators, The Idi Multipurpose Psoriasis Research on Vital Experiences (Improve) Investigators Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this author F. Sampogna, F. Sampogna Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorP. Gisondi, P. Gisondi Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorC.F. Melchi, C.F. Melchi Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorP. Amerio, P. Amerio Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorG. Girolomoni, G. Girolomoni Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorD. Abeni, D. Abeni Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this authorThe Idi Multipurpose Psoriasis Research on Vital Experiences (Improve) Investigators, The Idi Multipurpose Psoriasis Research on Vital Experiences (Improve) Investigators Istituto Dermopatico dell'Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy *Department of Dermatology, University of Chieti, Chieti, ItalySearch for more papers by this author First published: 16 September 2004 https://doi.org/10.1111/j.1365-2133.2004.06093.xCitations: 122 Damiano Abeni. E-mail: d.abeni@idi.it A complete list of the IMPROVE investigators who contributed to this study appears in the Acknowledgements. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Summary Background The main dermatology textbooks describe only in passing pruritus in psoriasis and rarely mention other symptoms. A quantification of the presence of symptoms is not available for clinical subgroups of psoriasis. Objectives To investigate the prevalence of symptoms experienced by patients with different clinical types of psoriasis. Methods The study was carried out in patients hospitalized for psoriasis between February 2000 and February 2002 at the inpatient wards of the Istituto Dermopatico dell'Immacolata, Rome, Italy. Symptoms were evaluated using the symptoms scale of Skindex-29. Clinical severity was assessed by the dermatologists using the Psoriasis Area and Severity Index (PASI), and by the patients completing the self-administered PASI. Psychiatric morbidity was evaluated using the 12-item General Health Questionnaire. Results In total, 936 eligible patients were analysed. The proportions of patients experiencing symptoms often or always in the 4 weeks before hospitalization were: 63·8% itching, 59·7% irritation, 46·1% burning/stinging, 39% sensitivity, 26% pain (from 10% in guttate psoriasis to 50% in arthropathic), 25·4% bleeding (17% pustular, 19% localized plaque, 36% palmoplantar), and 23·9% bothered by water (from 8·5% in the guttate form to 68% in palmoplantar). The prevalence of all symptoms was significantly higher in women and tended to increase with clinical severity. Conclusions Our study provides evidence of the high frequency of a number of symptoms in different subgroups of psoriasis patients determined by their sociodemographic characteristics, clinical type and disease severity. Symptoms represent a serious disabling factor in patients affected by psoriasis, including those with low levels of psychological distress. Dermatologists should include symptoms in the evaluation of disease severity both in clinical practice and in clinical trials. Citing Literature Volume151, Issue3September 2004Pages 594-599 RelatedInformation